Projected Income Statement: Viridien

Forecast Balance Sheet: Viridien

Forecast Balance Sheet - Viridien
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 988 951 974 921 888 747 665 633
Change - -3.74% 2.42% -5.44% -3.58% -15.88% -10.98% -4.81%
Announcement Date 3/3/22 3/2/23 3/6/24 2/27/25 2/26/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Viridien

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 226.9 260 232 285 207 286 270.5 267.5
Change - 14.59% -10.77% 22.84% -27.37% 38.16% -5.42% -1.11%
Free Cash Flow (FCF) 1 197.9 85.5 176.3 73.6 269.6 67.1 67.6 134.7
Change - -56.8% 106.2% -58.25% 266.3% -75.11% 0.75% 99.26%
Announcement Date 3/3/22 3/2/23 3/6/24 2/27/25 2/26/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Viridien

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 36.56% 46.77% 35.56% 37.78% 47.3% 43.65% 43.97% 44.11%
EBIT Margin (%) -2.47% 19.57% 10.58% 12.85% 20.37% 16.37% 19.51% 20.65%
EBT Margin (%) -19.78% 9% 1.77% 4.49% 7.89% 8.68% 12.62% 13.75%
Net margin (%) -19.18% 4.64% 1.15% 4.46% 6.1% 5.19% 8.55% 10.33%
FCF margin (%) 21.03% 9.21% 15.67% 6.59% 23.14% 6.25% 5.68% 10.61%
FCF / Net Income (%) -109.64% 198.38% 1,366.67% 147.79% 379.18% 120.46% 66.42% 102.66%

Profitability

        
ROA - - - - - - - -
ROE -17.34% 4.35% 1.26% 4.73% 6.42% 5.68% 9.21% 12.18%

Financial Health

        
Leverage (Debt/EBITDA) 2.87x 2.19x 2.44x 2.18x 1.61x 1.59x 1.27x 1.13x
Debt / Free cash flow 4.99x 11.12x 5.52x 12.51x 3.29x 11.13x 9.84x 4.7x

Capital Intensity

        
CAPEX / Current Assets (%) 24.11% 28.02% 20.62% 25.51% 17.77% 26.62% 22.72% 21.06%
CAPEX / EBITDA (%) 65.96% 59.91% 58% 67.54% 37.57% 61% 51.67% 47.75%
CAPEX / FCF (%) 114.65% 304.09% 131.59% 387.23% 76.78% 426.23% 400.15% 198.59%

Items per share

        
Cash flow per share 1 47.32 48.52 56.93 63.57 65.99 52.22 52.87 55.31
Change - 2.53% 17.34% 11.66% 3.81% -20.86% 1.24% 4.61%
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 135.3 147.3 147.6 151.5 157.4 180.2 202.7 227.4
Change - 8.89% 0.19% 2.66% 3.88% 14.53% 12.48% 12.17%
EPS 1 -25 6 2 6.93 9.85 9.263 16.31 22.03
Change - 124% -66.67% 246.5% 42.14% -5.96% 76.06% 35.08%
Nbr of stocks (in thousands) 7,116 7,123 7,137 7,161 7,180 7,219 7,219 7,219
Announcement Date 3/3/22 3/2/23 3/6/24 2/27/25 2/26/26 - - -
1USD
Estimates
2026 *2027 *
P/E 10.3x 5.84x
PBR 0.53x 0.47x
EV / Sales 1.37x 1.16x
Yield - -

EPS & Dividend

EPS & Dividend - Viridien


Y-o-Y evolution of P/E

Valuation ratios - P/E - Viridien
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Viridien
Trader
Investor
Global
Quality
ESG MSCI
AA
Ratings Surperformance© - Viridien
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
100.37USD
Average target price
157.75USD
Spread / Average Target
+57.17%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Viridien